Overall rank by patents
#9,972
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Atacor Medical, Inc.
USPTO PatentsView assignee record - 31 granted patents across 3 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
31
Total patents granted
3
CPC technology areas
21.6
Avg claims per patent
+188%
5-year filing velocity
The verdict
Atacor holds 31 US patents across 3 technology areas, rank #9,972 of 50,000 tracked assignees.
- #9,972
- of 50,000 US assignees by volume
- Top 39%
- by Innovation Score (39.2/100)
- 21.6
- avg claims per patent
- +188%
- filing velocity, last 5 yrs
Portfolio overview
AtaCor Medical, Inc. has been granted 31 US utility patents between 2017 and 2025, placing AtaCor Medical, Inc. at rank #9,972 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.6 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, AtaCor Medical, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 39.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 23 grants, compared with 8 in the 2015–2019 window, a +188% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. AtaCor Medical, Inc.'s 21.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark AtaCor Medical, Inc. against peers pursuing similar technology classes.
How does AtaCor compare?
Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Atacor Medical ◀ 31
AtaCor Medical, Inc.
31 patents
What this shows AtaCor holds 31 patents, placing it at rank #9,972 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
AtaCor's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 39% higher than 61% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
USPTO utility patent grants by year · 2017–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 6.5% |
| 2018 | 2 | 6.5% |
| 2019 | 4 | 12.9% |
| 2020 | 1 | 3.2% |
| 2021 | 4 | 12.9% |
| 2022 | 1 | 3.2% |
| 2023 | 3 | 9.7% |
| 2024 | 7 | 22.6% |
| 2025 | 7 | 22.6% |
Which technologies does AtaCor Medical, Inc. patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Accelerating
Frequently Asked Questions
How many patents does AtaCor Medical, Inc. hold?
AtaCor Medical, Inc. holds 31 US granted patents filed between 2017 and 2025, spanning 3 technology areas.
What is AtaCor Medical, Inc.'s Innovation Score?
AtaCor Medical, Inc. has an Innovation Score of 39.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does AtaCor Medical, Inc. focus on?
AtaCor Medical, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 31 patents. The company has filed patents in 3 CPC subclasses total.
Is AtaCor Medical, Inc.'s patent filing rate increasing or decreasing?
AtaCor Medical, Inc.'s recent filing velocity is +188% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for AtaCor Medical, Inc.'s patents?
AtaCor Medical, Inc.'s patents average 21.6 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the AtaCor Medical, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
How to use this portfolio
Atacor's 31 grants land it in the top 39% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Atacor ranks #9,972 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61N - see who else leads that technology area. A61N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Explore the patent dataset
A61N technology
AtaCor Medical, Inc.'s primary CPC class, all holders and yearly trends
Top 50 patent holders
See where AtaCor Medical, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Data sources used on this page
- USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
- Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
- USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov
